IKT

Inhibikase Therapeutics, Inc. is a biopharmaceutical company focused on developing therapies for neurodegenerative diseases. The company operates in the life sciences sector, with a particular emphasis on advancing drug candidates through clinical development. Its primary customers include healthcare providers and patients affected by these conditions. Inhibikase Therapeutics is involved in research and development activities, with a team experienced in various aspects of pharmaceutical development and operations.